Incyte Corporation (INCY)
NASDAQ
Closed
Aug 24, 2026
Day's Range
126.6552 wk Range
81.09Overview - INCY - Incyte Corporation
Key Statistics
Valuation
Enterprise Value
21.40B
P/E (Trailing)
‪16.28‬
P/E (Forward)
‪14.29‬
PEG Ratio
‪0.40‬
Price / Sales (TTM)
‪4.45‬
Price / Book
‪4.04‬
EV / EBITDA
‪11.02‬
Profitability
Gross Margin
‪93.72%‬
Profit Margin
‪27.70%‬
Operating Margin
‪41.89%‬
Return on Assets
‪16.83%‬
Return on Equity
‪30.66%‬
Ownership
Shares Outstanding
200.97M
Float
170.74M
Short % of Shares Outstanding
‪8.62%‬
Held by Insiders
‪1.83%‬
Held by Institutions
‪103.83%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪116.20‬
200-Day Avg
‪103.65‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
27 analysts
Average price target
‪$ 125.17‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - INCY - Incyte Corporation
Peers - INCY - Incyte Corporation
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- INCYNASDAQIncyte Corporation25.90BMarket Cap+33.68%52-week change16.28P/E (Trailing)‪27.70%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt65.04BMarket Cap+34.86%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+23.98%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - INCY - Incyte Corporation
About
Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics for serious medical conditions. The company concentrates on hematology and oncology, as well as inflammation, autoimmunity, and dermatology, addressing diseases with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
